Surgery Godfather
Chapter 1126 - 904: Hunt

Chapter 1126: Chapter 904: Hunt

Headquarters of BG Company, United States.

The more extensive and detailed the intelligence gathering on Yang Ping became, the more reports landed in Li Gaoyang’s hands, leaving him now with a headache and caught between a rock and a hard place, wondering what to do.

With the help of his think tank, Li Gaoyang finally managed to make sense of the tangled web of intelligence.

The reason Yang Ping was so uncompromising, refusing Langnaife’s invitation, and showing no interest in any of BG Company’s terms, was likely due to his association with a Chinese company behind the scenes.

Ruixing Medical stepped into Li Gaoyang’s field of vision, and intelligence indicated a very close relationship between the company and Yang Ping.

Whenever Yang Ping was in need, the company seemed to provide funding continuously.

Moreover, the company’s profitability was incredibly strong, having risen to prominence only recently but at a staggering pace.

It virtually seized a sizable market share like lightning, and then rolled out an extensive and broad product line.

Initially starting from orthopedic sports medicine products, it expanded to the entire orthopedic product line, then to the entire surgical product line, and finally, the company grew its product line to encompass various pharmaceuticals and medical instruments, showing clear potential to emerge as an international giant.

That company was Yang Ping’s strongest backing in scientific research because it not only provided funding for his medical research but also offered hardware support for his medical experiments.

Currently, the company was working on cutting-edge biological 3D printers solely to align with Yang Ping’s research plan.

It appeared that this company was only a part of Yang Ping’s enormous research plans, so Li Gaoyang could conclude that this company was likely the most vital link in Yang Ping’s entire research initiatives.

"We’ve underestimated this Chinese doctor. We’re dealing with a system, not an individual," Li Gaoyang said, narrowing his eyes.

Feeling ashamed, Rolf, sitting across from him, said, "This is a major oversight in my intelligence gathering. I oversimplified the situation."

Li Gaoyang, looking at the piles upon piles of thick intelligence materials on the desktop, fell deep into thought.

It seemed impossible to bring Yang Ping on board since he had his own self-sufficient scientific research system and didn’t need to seek shelter under the BG Company’s banner. Moreover, his lack of interest in the United States was not just talk—it was authentic.

If he didn’t covet anything from the United States or BG Company, why did he come to the United States?

The reasoning was simple; If Li Gaoyang, like himself, were offered a high annual salary by a Chinese company to go work in China, and he had no interest in China, was unaccustomed to life there, and still held a stake in an American company where his income far exceeded the so-called annual salary, why would he go to China?

If they couldn’t bring Yang Ping on board, the only alternative was to steal all his research results and then ruthlessly suppress him and his team.

To suppress him meant they had to vie with him, and this contest would be between one system and another—not merely personal competition.

But the intelligence was too large and complex; currently, Li Gaoyang could only grasp the surface phenomena and was still unclear about the connections behind this intelligence.

For instance, Yang Ping was backed by an independent research fund whose sole purpose was to provide a consistent flow of capital for his scientific research.

Li Gaoyang found it odd because the fund had a very broad range of sources of capital, and there seemed to be little strong connection between these sources.

According to intelligence, many companies had invested funds into this research fund.

These included domestic Chinese enterprises such as Anning Group and Changxin Mining, as well as the Duke’s Fund from Europe, Guo’s Wealth Group from Southeast Asia, with the European Duke’s Fund injecting a staggering one billion euros in stages.

For a researcher, one billion euros is an enormous sum.

With so many financiers behind it, who was really in charge? Li Gaoyang couldn’t figure it out.

Not only could Li Gaoyang not figure it out, but even Rolf, who specialized in intelligence gathering and analysis, wasn’t clear about who the main orchestrator was—the real big boss.

For example, BG Company owned countless pharmaceutical businesses and medical biological laboratories through various means.

Had a professional intelligence agency analyzed it, they might have been able to clarify and identify BG Company as the ultimate boss behind it all.

However, from the analysis of the intelligence concerning Yang Ping, it was impossible to identify the primary controller of the entire system, but it was certain that Ruixing Medical had an extremely close relationship with Yang Ping.

The think tank’s strategy was to target Ruixing Medical to weaken the support behind Yang Ping. However, even if they attacked Ruixing Medical, it seemed it wouldn’t pose a threat to Yang Ping because many consortia were still surrounding him, and in terms of financial power, Anning Group was far stronger than Ruixing.

The think tank’s advice was to strike Ruixing first; only then would the hidden forces emerge. Ruixing was a key link in the chain, and as the Chinese Art of War would put it, "attack where the enemy must rescue."

The head of Ruixing Medical was a formidable character, capable of rapidly scaling Ruixing to such a size, which was not something just anyone could achieve.

According to intelligence, this individual had led Ruixing in dismantling the encirclement of giant companies, turning defeat into victory with merciless resolve, pursuing their adversaries to maximize their triumph and laying a solid foundation for Ruixing’s development.